A phase I study of topical tempol for the prevention of alopecia induced by whole brain radiotherapy

Clinical Cancer Research

Volumn 10, Issue 19, 2004, Pages 6411-6417

  Metz, James M ^a   Smith, Debbie ^a   Mick, Rosemarie ^a   Lustig, Robert ^a   Mitchell, James ^b   Cherakuri, Murali ^b   Glatstein, Eli ^a   Hahn, Stephen M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROXIDE; TEMPOL;

ADULT; AGED; ALOPECIA; ARTICLE; BRAIN METASTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; HYPOGLYCEMIA; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SCALP; SENSORY DYSFUNCTION; SKIN TINGLING; XEROSIS;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ALOPECIA; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN NEOPLASMS; CYCLIC N-OXIDES; FEMALE; FOLLOW-UP STUDIES; HAIR; HEART RATE; HUMANS; MALE; MIDDLE AGED; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; SPIN LABELS; TIME FACTORS; TREATMENT OUTCOME;

EID: 5144231707     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0658     Document Type: Article

References (16)

1. Marks JE, Baglan RJ, Wong J. Radiation damage in brain and cranial soft tissues: outcome and incidence before and after reduction in dose. Walker MD and Thomas DG, editors. Boston (MA) Nijhoff Publishers, Biology Brain Tumour 1986;44:325-34.
2. Baxley KO, Erdman LK, Henry EB, et al. Alopecia: effect on cancer patients' body image. Cancer Nurs 1984;7:499-500.
3. Lancaster I. About radiotherapy. Part II. Side effects and staff protection. Nurs RSA 1989;4:41-3.
4. Kim JA, Baker DG, Hahn SS, et al. Topical use of n-acetylcysteine for reduction in skin reaction to radiation therapy. Semin Oncol 1989; 10:86-92.
5. Goffman T, Cuscela D, Glass J, et al. Topical application of nitroxide protects radiation induced alopecia in guinea pigs. Int J Radiat Oncol Biol Phys 1992;22:803-6.
6. Cuscela D, Coffin D, Lupton GP, et at. Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies. Cancer I Sci Am 1996;2:273-8.
7. Mitchell JB, Samuni A, Krishna MC, et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990; 29:2802-7.
8. Samuni A, Winkelsberg D, Pinson A, et at. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J Clin Investig 1991;87:1526-30.
9. Mitchell JB, DeGraff W, Kaufman D, et al. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, Tempol. Arch Biochem Biophys 1991;289:62-70.
10. Hahn SM, Tochner Z, Krishna CM, et at. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res 1992;52: 1750-3.
11. Price VH, Menefee E. Quantitative estimation of hair growth I. Androgenetic alopecia in women: effect of minoxidil. Investig Dermatol 1990;95:683-7.
12. Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 1993;32: 758-62.
13. Katz HI. Topical minoxidil: review of efficacy and safety. Cutis 1989;43:94-8.
14. Whiting DA, Jacobson C. Treatment of female androgenetic alopecia with minoxidil 20%. Int J Dermatol 1992;31:800-4.
15. Couet WR, Brasch RC, Sosnovsky G, et al. Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates. Magn Reson Imaging 1985;3:83-8.
16. Hahn SM, Sullivan FJ, DeLuca AM, et al. Evaluation of tumor radioprotection in a murine tumor model. Free Radic Biol Med 1997;22.